Surgery may be necessary to address conditions like adrenal tumors, hyperaldosteronism, or Cushing’s syndrome that affect adrenal gland function.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Recovery includes managing pain, following post-operative care instructions, and undergoing rehabilitation for speech and swallowing if needed. Follow-up visits are crucial for monitoring progress.